MedPath

An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects.

Not Applicable
Completed
Conditions
Candidiasis, Oral
HIV Infections
Registration Number
NCT00002133
Lead Sponsor
Janssen, LP
Brief Summary

To assess the efficacy and safety of itraconazole oral solution in HIV-seropositive patients with oropharyngeal candidiasis that is refractory to fluconazole.

Detailed Description

Patients receive itraconazole oral solution twice daily. Per 08/15/94 amendment, patients with complete resolution of oropharyngeal candidiasis lesions upon completion of treatment are eligible for maintenance treatment on protocol FDA 236C. Patients who decline maintenance are followed for 6 weeks. Patients who relapse during follow-up are re-treated for 14-28 days; if lesions clear, patients may enter the maintenance protocol.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (18)

Pennsylvania Hosp

🇺🇸

Philadelphia, Pennsylvania, United States

Infectious Disease Clinic

🇺🇸

Nashville, Tennessee, United States

Ohio State Univ Hosp

🇺🇸

Columbus, Ohio, United States

Ann Arbor Veterans Administration Med Ctr

🇺🇸

Ann Arbor, Michigan, United States

Washington Univ

🇺🇸

St. Louis, Missouri, United States

Kaiser Permanente Med Ctr

🇺🇸

San Francisco, California, United States

George Washington Univ Med Ctr

🇺🇸

Washington, District of Columbia, United States

Infectious Diseases Research Clinic / Indiana Univ Hosp

🇺🇸

Indianapolis, Indiana, United States

Oklahoma City Veterans Administration Med Ctr

🇺🇸

Oklahoma City, Oklahoma, United States

East Bay AIDS Ctr

🇺🇸

Berkeley, California, United States

Univ of Arkansas for Med Sciences

🇺🇸

Little Rock, Arkansas, United States

Dr Douglas Ward

🇺🇸

Washington, District of Columbia, United States

Univ of Alabama at Birmingham

🇺🇸

Birmingham, Alabama, United States

Veterans Administration Med Ctr

🇺🇸

Washington, District of Columbia, United States

Natl Inst of Allergy & Infect Dis / Cln Ctr

🇺🇸

Bethesda, Maryland, United States

Wayne State Univ / Harper Hosp

🇺🇸

Detroit, Michigan, United States

Audie L Murphy Veterans Administration Hosp

🇺🇸

San Antonio, Texas, United States

Univ of Virginia Health Sciences Ctr

🇺🇸

Charlottesville, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath